Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,425.00    0.00 (0.00%)
Bid:
5,400.00
Ask:
5,450.00
Spread: 50.00 (0.926%)
Market Cap: £137.13m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

Directorate Changes

6 Mar 2020 07:00

RNS Number : 2063F
Camellia PLC
06 March 2020
 

6 March 2020

 

Camellia Plc

(the "Company")

 

Directorate Changes

 

Camellia Plc is pleased to announce the following changes to the Board.

 

Appointment of Simon Turner as a non-executive director with effect from 6 March 2020.

 

Simon is President of the board of the trustee of The Camellia Foundation, a Bermudian trust, the income of which is utilised for charitable, educational and humanitarian causes at the discretion of the trustees. Through its subsidiary, The Camellia Foundation controls 51.67 per cent. of the voting rights of Camellia Plc.

 

Appointment of Jonathon Bond as an independent non-executive director with effect from 6 March 2020.

 

Jonathon spent 25 years in the private equity industry with a particular focus on raising standards of governance and performance. He has extensive international and general management experience, having founded and served on the board of several significant businesses including Jupiter Asset Management Plc.

 

Further information, as required pursuant to Schedule 2(g) of the AIM Rules for Companies, is set out below:-

 

Simon Charles Turner, aged 44

 

Current directorships/partnerships

Past directorships/partnerships within the last 5 years

 

The Camellia Foundation (UK)

None

Camellia Holding AG (Switzerland)

 

The Camellia Private Trust Company Ltd (Bermuda)

 

 

Jonathon Roderick Alan Bond, aged 56

 

Current directorships/partnerships

Past directorships/partnerships within the last 5 years

 

Chalke Valley History Festivals Limited

Blu Homes (USA)

CV Schools History Festival Limited

Ecover (UK) Limited

Giles W. Pritchard-Gordon & Co. Limited

Farncombe Estate Holdings Limited

Grosvenor Limited

LM Holdings EF Limited

Grosvenor UK Finance Plc

Method Products Limited

HBOS Investment Fund Managers Limited

Number One Lansdowne Gardens Limited

Institute of Business Ethics

People Against Dirty Holdings Limited

Jupiter Fund Management Plc

People Against Dirty UK Limited

Lloyds Bank General Insurance Holdings Limited

Ruths Hotel (Denmark)

Lloyds Bank General Insurance Limited

Sccl 3 Limited

One54 Holdings Ltd

Sccl 4 Limited

S.J.P. Trust Corporation Limited

Sccl 4 Services Limited

Scottish Widows Financial Services Holdings

Skagen Conscience Capital Limited

Scottish Widows Group Limited

Skagen Property Limited

Scottish Widows Limited

Skagen Ro Limited

Scottish Widows Unit Trust Managers Limited

The Stockwell Partnership Limited

St Andrew's Insurance Plc

The Young Musicians Symphony Orchestra

Standard Life Private Equity Trust Plc

 

 

There are no further disclosures required under Schedule 2(g) of the AIM Rules for Companies.

 

Camellia Plc 01622 746655

Malcolm Perkins, Chairman

Tom Franks, CEO

 

Panmure Gordon & Co (Nominated Adviser and Broker) 020 7886 2500

Emma Earl

Erik Anderson

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUVOBRROUORAR
Date   Source Headline
4th Jun 202612:31 pmRNSResult of AGM
22nd May 20267:00 amRNSSale of Chalouni Tea Estate
5th May 20267:00 amRNSFinal Results
7th Apr 20264:19 pmRNSProposed Sale of Chalouni Tea Estate
1st Apr 20267:00 amRNSArtwork Sale and Update on Indian Tea Estate MOU
23rd Feb 20267:00 amRNSTrading Update
23rd Jan 20267:00 amRNSDirectorate change
27th Nov 20257:00 amRNSKakuzi Land Claims
8th Sep 20254:47 pmRNSDirector/PDMR Shareholding
5th Sep 20257:00 amRNSHalf Year Results
26th Aug 20257:00 amRNSNotice of Half Year Results
4th Jul 20254:30 pmRNSDisposal
13th Jun 20254:01 pmRNSHolding(s) in Company
13th Jun 20252:35 pmRNSHolding(s) in Company
10th Jun 20259:09 amRNSHolding(s) in Company
9th Jun 20254:39 pmRNSHolding(s) in Company 9 June 2025
6th Jun 20257:00 amRNSResult of Tender Offer
5th Jun 20252:02 pmRNSResult of General Meetings
19th May 20257:00 amRNSValue Enhancement Plan
19th May 20257:00 amRNSTender Offer
13th May 20257:00 amRNSHolding(s) in Company
9th May 20257:00 amRNSTransaction in Own Shares
8th May 20257:00 amRNSValue Enhancement Plan Date & Presentation
30th Apr 20257:00 amRNSFinal Results
28th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20257:00 amRNSTransaction in Own Shares
24th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20257:00 amRNSPotential Disposal
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20259:07 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSDisposal
11th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20257:00 amRNSTransaction in Own Shares
26th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
20th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20257:00 amRNSTransaction in Own Shares
12th Feb 20257:00 amRNSPotential Disposal
11th Feb 20257:00 amRNSTransaction in Own Shares
10th Feb 20257:00 amRNSTransaction in Own Shares
7th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.